Tempus AI (NASDAQ:TEM – Get Free Report) and PubMatic (NASDAQ:PUBM – Get Free Report) are each medical corporations, however which is the superior inventory? We’ll distinction the 2 corporations based mostly on the energy of their institutional possession, dividends, analyst suggestions, profitability, threat, valuation and earnings.
Institutional and Insider Possession
64.3% of PubMatic shares are owned by institutional buyers. 2.9% of PubMatic shares are owned by firm insiders. Robust institutional possession is a sign that hedge funds, giant cash managers and endowments imagine a inventory will outperform the market over the long run.
Analyst Scores
It is a breakdown of present scores and goal costs for Tempus AI and PubMatic, as offered by MarketBeat.com.
| Promote Scores | Maintain Scores | Purchase Scores | Robust Purchase Scores | Score Rating | |
| Tempus AI | 0 | 1 | 9 | 0 | 2.90 |
| PubMatic | 0 | 3 | 4 | 0 | 2.57 |
Tempus AI presently has a consensus value goal of $45.56, indicating a possible draw back of seven.46%. PubMatic has a consensus value goal of $21.00, indicating a possible upside of 43.74%. Given PubMatic’s increased potential upside, analysts plainly imagine PubMatic is extra favorable than Tempus AI.
Earnings and Valuation
This desk compares Tempus AI and PubMatic”s top-line income, earnings per share and valuation.
| Gross Income | Worth/Gross sales Ratio | Internet Earnings | Earnings Per Share | Worth/Earnings Ratio | |
| Tempus AI | $595.57 million | 13.63 | N/A | N/A | N/A |
| PubMatic | $267.01 million | 2.71 | $8.88 million | $0.21 | 69.57 |
PubMatic has decrease income, however increased earnings than Tempus AI.
Profitability
This desk compares Tempus AI and PubMatic’s internet margins, return on fairness and return on belongings.
| Internet Margins | Return on Fairness | Return on Belongings | |
| Tempus AI | N/A | N/A | N/A |
| PubMatic | 7.08% | 6.92% | 3.07% |
Abstract
PubMatic beats Tempus AI on 6 of the ten components in contrast between the 2 shares.
About Tempus AI
Tempus AI Inc. is a expertise firm advancing precision drugs via the sensible software of synthetic intelligence principally in healthcare. The corporate supplies AI-enabled precision drugs options to physicians to ship personalised affected person care and in parallel facilitates discovery, improvement and supply of optimum therapeutics. Tempus AI Inc. is predicated in CHICAGO.
About PubMatic
PubMatic, Inc., a expertise firm, engages within the provision of a cloud infrastructure platform that permits real-time programmatic promoting transactions for digital content material creators, advertisers, companies, company buying and selling desks, and demand aspect platforms worldwide. Its PubMatic SSP, a sell-side platform, used for the acquisition and sale of digital promoting stock for publishers and patrons. The corporate additionally supplies options, together with OpenWrap, a header bidding answer; Openwrap OTT, a prebid-powered unified bidding answer; Openwrap SDK, an enterprise-grade administration instruments and analytics; Join, an answer that gives extra knowledge and insights to publishers and patrons; Activate, which permits patrons to execute direct offers on its platform throughout writer stock; Convert, a commerce media answer; and Identification Hub, an ID administration instrument for publishers that leverages specialised expertise?infrastructure?to simplify the complicated different identifier market. Its platform helps an array of advert codecs and digital machine sorts, together with cellular app, cellular internet, desktop, show, video, over-the-top (OTT), linked tv, and media. The corporate was integrated in 2006 and is predicated in Redwood Metropolis, California.
Obtain Information & Scores for Tempus AI Each day – Enter your e mail deal with beneath to obtain a concise every day abstract of the newest information and analysts’ scores for Tempus AI and associated corporations with MarketBeat.com’s FREE every day e mail publication.
